Back to Gastroenterology
GastroenterologyvCombined 2023Evidence-Based

Model for End-Stage Liver Disease (Combined MELD)

Offers multiple versions of MELD for liver transplant planning and end-stage liver disease severity assessment

Clinical Input Parameters

mg/dL
Range: 0.1 — 50 mg/dL
mg/dL
Range: 0.1 — 15 mg/dL
Range: 0.8 — 10
mEq/L
Range: 120 — 160 mEq/L
g/dL
Range: 1 — 6 g/dL
years
Range: 12 — 120 years
Clinical Assessment
Awaiting Parameters
meld score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Model for End-Stage Liver Disease (Combined MELD) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Version-specific formulas: Original MELD = 3.78×ln(bilirubin) + 11.2×ln(INR) + 9.57×ln(creatinine) + 6.43; MELD-Na incorporates sodium; MELD 3.0 includes albumin, age, and sex adjustments

Clinical Pearls & Practice Notes

  • MELD 3.0 is the current standard for organ transplantation (effective 2023)
  • Use most recent lab values within 48 hours
  • Maximum creatinine of 4.0 mg/dL used in calculations if higher
  • Minimum values: bilirubin 1.0 mg/dL, creatinine 1.0 mg/dL, INR 1.0
  • Sodium clamped between 125-137 mEq/L for MELD-Na calculations
  • Patients under 12 years should use PELD (Pediatric End-Stage Liver Disease) score
  • OPTN accepts maximum submitted score of 40
  • Score should be recalculated as lab values change
  • Different formulas apply for ages 12-18 vs ≥18 years in MELD 3.0

Evidence & Literature Citations

  1. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001 Feb;33(2):464-70. doi: 10.1053/jhep.2001.22172.
  2. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003 Jan;124(1):91-6. doi: 10.1053/gast.2003.50016.
  3. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008 Sep 4;359(10):1018-26. doi: 10.1056/NEJMoa0801209.
  4. Kwong AJ, Ebel NH, Kim WR, Lake JR, Smith JM, Schladt DP, et al. OPTN/SRTR 2021 Annual Data Report: Liver. Am J Transplant. 2023 Feb;23(2 Suppl 1):S178-S263. doi: 10.1016/j.ajt.2023.02.006.
  5. Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW, et al. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era. Gastroenterology. 2021 Dec;161(6):1887-1895.e4. doi: 10.1053/j.gastro.2021.08.050.

Score Interpretation Ranges

Mild Disease6 – 9 pts

Lower mortality risk

Moderate Disease10 – 14 pts

Moderate mortality risk

Severe Disease15 – 19 pts

High mortality risk

Very Severe Disease20 – 29 pts

Very high mortality risk

Critical Disease30 – 40 pts

Extremely high mortality risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.